359 related articles for article (PubMed ID: 19913029)
21. Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.
Toledo D; Ramon E; Aguilà M; Cordomí A; Pérez JJ; Mendes HF; Cheetham ME; Garriga P
J Biol Chem; 2011 Nov; 286(46):39993-40001. PubMed ID: 21940625
[TBL] [Abstract][Full Text] [Related]
22. High-throughput screening assays to identify small molecules preventing photoreceptor degeneration caused by the rhodopsin P23H mutation.
Chen Y; Tang H
Methods Mol Biol; 2015; 1271():369-90. PubMed ID: 25697536
[TBL] [Abstract][Full Text] [Related]
23. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation.
Saliba RS; Munro PM; Luthert PJ; Cheetham ME
J Cell Sci; 2002 Jul; 115(Pt 14):2907-18. PubMed ID: 12082151
[TBL] [Abstract][Full Text] [Related]
24. Understanding rhodopsin mutations linked to the retinitis pigmentosa disease: a QM/MM and DFT/MRCI study.
Hernández-Rodríguez EW; Sánchez-García E; Crespo-Otero R; Montero-Alejo AL; Montero LA; Thiel W
J Phys Chem B; 2012 Jan; 116(3):1060-76. PubMed ID: 22126625
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
[TBL] [Abstract][Full Text] [Related]
26. Flavonoids improve the stability and function of P23H rhodopsin slowing down the progression of retinitis pigmentosa in mice.
Ortega JT; Parmar T; Carmena-Bargueño M; Pérez-Sánchez H; Jastrzebska B
J Neurosci Res; 2022 Apr; 100(4):1063-1083. PubMed ID: 35165923
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological manipulation of rhodopsin retinitis pigmentosa.
Mendes HF; Zaccarini R; Cheetham ME
Adv Exp Med Biol; 2010; 664():317-23. PubMed ID: 20238031
[TBL] [Abstract][Full Text] [Related]
28. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological clearance of misfolded rhodopsin for the treatment of RHO-associated retinitis pigmentosa.
Liu X; Feng B; Vats A; Tang H; Seibel W; Swaroop M; Tawa G; Zheng W; Byrne L; Schurdak M; Chen Y
FASEB J; 2020 Aug; 34(8):10146-10167. PubMed ID: 32536017
[TBL] [Abstract][Full Text] [Related]
30. The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa.
Parfitt DA; Aguila M; McCulley CH; Bevilacqua D; Mendes HF; Athanasiou D; Novoselov SS; Kanuga N; Munro PM; Coffey PJ; Kalmar B; Greensmith L; Cheetham ME
Cell Death Dis; 2014 May; 5(5):e1236. PubMed ID: 24853414
[TBL] [Abstract][Full Text] [Related]
31. Mutation screening of the peropsin gene, a retinal pigment epithelium specific rhodopsin homolog, in patients with retinitis pigmentosa and allied diseases.
Rivolta C; Berson EL; Dryja TP
Mol Vis; 2006 Dec; 12():1511-5. PubMed ID: 17167409
[TBL] [Abstract][Full Text] [Related]
32. Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa.
Maw MA; Kennedy B; Knight A; Bridges R; Roth KE; Mani EJ; Mukkadan JK; Nancarrow D; Crabb JW; Denton MJ
Nat Genet; 1997 Oct; 17(2):198-200. PubMed ID: 9326942
[TBL] [Abstract][Full Text] [Related]
33. [Structural development study of a novel pharmacological chaperone for folding-defective rhodopsin mutants responsible for retinitis pigmentosa].
Ohgane K; Dodo K; Hashimoto Y
Yakugaku Zasshi; 2011 Mar; 131(3):325-34. PubMed ID: 21372525
[TBL] [Abstract][Full Text] [Related]
34. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa.
Green ES; Menz MD; LaVail MM; Flannery JG
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1546-53. PubMed ID: 10798675
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of the second extracellular loop of rhodopsin by characterizing split variants.
Sakai K; Imamoto Y; Yamashita T; Shichida Y
Photochem Photobiol Sci; 2010 Nov; 9(11):1490-7. PubMed ID: 20886156
[TBL] [Abstract][Full Text] [Related]
36. The dependence of retinal degeneration caused by the rhodopsin P23H mutation on light exposure and vitamin a deprivation.
Tam BM; Qazalbash A; Lee HC; Moritz OL
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1327-34. PubMed ID: 19933196
[TBL] [Abstract][Full Text] [Related]
37. Rhodopsin regeneration is accelerated via noncovalent 11-cis retinal-opsin complex--a role of retinal binding pocket of opsin.
Matsumoto H; Yoshizawa T
Photochem Photobiol; 2008; 84(4):985-9. PubMed ID: 18399914
[TBL] [Abstract][Full Text] [Related]
38. A naturally occurring mutation of the opsin gene (T4R) in dogs affects glycosylation and stability of the G protein-coupled receptor.
Zhu L; Jang GF; Jastrzebska B; Filipek S; Pearce-Kelling SE; Aguirre GD; Stenkamp RE; Acland GM; Palczewski K
J Biol Chem; 2004 Dec; 279(51):53828-39. PubMed ID: 15459196
[TBL] [Abstract][Full Text] [Related]
39. An experimental comparison of human and bovine rhodopsin provides insight into the molecular basis of retinal disease.
Morrow JM; Castiglione GM; Dungan SZ; Tang PL; Bhattacharyya N; Hauser FE; Chang BSW
FEBS Lett; 2017 Jun; 591(12):1720-1731. PubMed ID: 28369862
[TBL] [Abstract][Full Text] [Related]
40. Misfolded opsin mutants display elevated β-sheet structure.
Miller LM; Gragg M; Kim TG; Park PS
FEBS Lett; 2015 Oct; 589(20 Pt B):3119-25. PubMed ID: 26358292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
